Trial Profile
A Randomized, Open-label, Single Dose, Parallel Study to Evaluate the Pharmacokinetics Dose Proportionality of GLA5PR GLARS-NF1 Tablet in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors GL PharmTech
- 06 Jan 2015 New trial record